LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 81.55%-10.24M | -159.54%-21.67M | 101.52%1.44M | -27.52%-114.79M | -100.94%-1.16M | -112.88%-55.53M | 143.23%36.4M | 7.63%-94.51M | -90.02M | 122.57M |
Net income from continuing operations | 91.96%-6.37M | 12.57%-70.65M | 110.61%8.61M | -6.43%-304.71M | 24.39%-63.59M | 38.30%-79.21M | -86.09%-80.8M | -166.76%-81.11M | ---286.3M | ---84.1M |
Operating gains losses | --0 | --0 | --375K | -80.17%3.91M | --0 | 5,314.29%758K | ---- | ---- | --19.72M | --890K |
Depreciation and amortization | -11.16%5.8M | -27.35%5.3M | -22.94%5.81M | -31.50%32.79M | 29.95%11.42M | -66.31%6.52M | -13.84%7.3M | -32.91%7.54M | --47.87M | --8.79M |
Deferred tax | -51.28%1.03M | -215.01%-1.56M | -119.63%-127K | -65.09%6.56M | -57.12%2.45M | -95.64%2.12M | 106.80%1.35M | 104.16%647K | --18.8M | --5.71M |
Other non cash items | -45.14%6.36M | 1,071.07%5.59M | -18.50%-4.22M | 104.69%47K | -62.39%-8.46M | 749.52%11.6M | -63.45%477K | -331.45%-3.56M | ---1M | ---5.21M |
Change In working capital | -190.46%-22.62M | -75.53%23.42M | 34.67%-16.96M | 39.96%110.55M | -74.17%48.59M | -131.53%-7.79M | 335.36%95.7M | 72.14%-25.95M | --78.99M | --188.1M |
-Change in receivables | -1,612.03%-31.31M | 32.21%-29.33M | 3.82%38.57M | -112.40%-11.75M | -105.36%-3.81M | 96.08%-1.83M | -369.15%-43.26M | -31.59%37.15M | --94.75M | --70.98M |
-Change in inventory | 39.22%-46.39M | -65.22%19.58M | -69.28%16.27M | 154.48%125.71M | -31.20%92.78M | -407.17%-76.31M | 181.94%56.3M | 3,236.67%52.95M | --49.4M | --134.85M |
-Change in payables and accrued expense | -7.63%65.6M | -81.17%13.09M | 32.96%-77.83M | 85.19%-17.35M | -8.53%-41.77M | 203.04%71.01M | 311.27%69.51M | 2.47%-116.1M | ---117.19M | ---38.49M |
-Change in other current assets | -1,493.79%-10.52M | 52.63%20.07M | 11,305.66%6.05M | -73.21%13.94M | -93.27%1.4M | -101.05%-660K | 367.13%13.15M | 100.20%53K | --52.03M | --20.76M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 81.55%-10.24M | -159.54%-21.67M | 101.52%1.44M | -27.52%-114.79M | -100.94%-1.16M | -112.88%-55.53M | 143.23%36.4M | 7.63%-94.51M | ---90.02M | --122.57M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 98.51%-10K | 95.98%-46K | 92.28%-118K | -237.68%-3.1M | 107.29%250K | 81.91%-673K | 64.29%-1.14M | -112.13%-1.53M | 2.25M | -3.43M |
Net PPE purchase and sale | --0 | --0 | 91.90%-118K | 76.78%-2.86M | 107.87%270K | 84.55%-618K | 40.60%-1.06M | 53.23%-1.46M | ---12.33M | ---3.43M |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment purchase and sale | 81.82%-10K | 45.88%-46K | --0 | -101.60%-233K | ---20K | -119.64%-55K | 94.01%-85K | -100.46%-73K | --14.57M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 98.51%-10K | 95.98%-46K | 92.28%-118K | -237.68%-3.1M | 107.29%250K | 81.91%-673K | 64.29%-1.14M | -112.13%-1.53M | --2.25M | ---3.43M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -99.29%1.34M | 144.08%12M | -217.85%-29.94M | 6,196.54%185.37M | 99.01%-878K | 241.85%188.06M | -173.14%-27.22M | 3,595.05%25.41M | 2.94M | -88.56M |
Net issuance payments of debt | --0 | --0 | -229.43%-34.95M | --200M | --0 | 263.64%200M | -177.14%-27M | --27M | --0 | ---90M |
Net common stock issuance | --1.42M | --12.31M | --5.63M | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | -99.81%9K | --0 | --0 | --0 | -98.87%9K | --4.72M | --1.45M |
Net other financing activities | 99.33%-80K | -42.01%-311K | 60.69%-629K | -724.73%-14.64M | ---878K | -6,763.22%-11.94M | -184.42%-219K | -4.99%-1.6M | ---1.78M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -99.29%1.34M | 144.08%12M | -217.85%-29.94M | 6,196.54%185.37M | 99.01%-878K | 241.85%188.06M | -173.14%-27.22M | 3,595.05%25.41M | --2.94M | ---88.56M |
Net cash flow | ||||||||||
Beginning cash position | 159.51%150.4M | 234.23%160.14M | 59.30%187.89M | -41.45%117.95M | 113.65%191.41M | -8.60%57.95M | -57.23%47.92M | -41.45%117.95M | --201.46M | --89.59M |
Current changes in cash | -106.76%-8.92M | -220.95%-9.72M | 59.47%-28.63M | 179.55%67.48M | -105.83%-1.78M | 423.08%131.86M | 116.01%8.03M | 21.91%-70.63M | ---84.83M | --30.59M |
Effect of exchange rate changes | -75.05%398K | -101.45%-29K | 48.74%882K | 85.92%2.46M | 22.04%-1.74M | 64.26%1.6M | 28.94%2.01M | -42.03%593K | --1.32M | ---2.23M |
End cash Position | -25.88%141.88M | 159.51%150.4M | 234.23%160.14M | 59.30%187.89M | 59.30%187.89M | 113.65%191.41M | -8.60%57.95M | -57.23%47.92M | --117.95M | --117.95M |
Free cash flow | 81.76%-10.24M | -161.32%-21.67M | 101.37%1.32M | -14.96%-117.66M | -100.74%-886K | -86.62%-56.14M | 141.10%35.34M | 8.98%-95.96M | ---102.35M | --119.14M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |